- Telehealth Visits
Carly Hoffman, NP, RN
PediatricsOn this page
About me
Carly Hoffman is a pediatric nurse practitioner who cares for neuro-oncology patients receiving chemotherapy. She has special interests in managing chemotherapy symptoms, and in being a patient advocate and liaison for families of children undergoing treatment. Working with the pediatric neurosurgery team, she also cares for patients who have had surgery for a known or suspected brain tumor. Her goal is to ensure her patients' comfort while they are in the hospital. She is certified in both acute care and pediatric oncology.
Hoffman received her bachelor's degree in nursing from Dominican University of California and her master's degree from the UCSF School of Nursing, where she completed the Pediatric Nurse Practitioner – Acute Care Program.
Hoffman is a member of the Association of Pediatric Hematology/Oncology Nurses, serving a term as president of its San Francisco Bay Area chapter.
Hoffman volunteers as a medical chaperone with the Sunshine Kids and Shining Stars Foundation, nonprofit organizations that provide social programs for children in cancer treatment.
Education
Board Certification
- Pediatric Acute Care NP, Pediatric Nursing Certification Board (PNCB)
School
- MSN, UCSF School of Nursing
Care Keywords
Services
- Pediatrics
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222329%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222329%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.